The use of nanocrystalline cellulose for the binding and controlled release of drugs.

297Citations
Citations of this article
371Readers
Mendeley users who have this article in their library.

Abstract

The objective of this work was to investigate the use of nanocrystalline cellulose (NCC) as a drug delivery excipient. NCC crystallites, prepared by an acid hydrolysis method, were shown to have nanoscopic dimensions and exhibit a high degree of crystallinity. These crystallites bound significant quantities of the water soluble, ionizable drugs tetratcycline and doxorubicin, which were released rapidly over a 1-day period. Cetyl trimethylammonium bromide (CTAB) was bound to the surface of NCC and increased the zeta potential in a concentration-dependent manner from -55 to 0 mV. NCC crystallites with CTAB-modified surfaces bound significant quantities of the hydrophobic anticancer drugs docetaxel, paclitaxel, and etoposide. These drugs were released in a controlled manner over a 2-day period. The NCC-CTAB complexes were found to bind to KU-7 cells, and evidence of cellular uptake was observed.

Cite

CITATION STYLE

APA

Jackson, J. K., Letchford, K., Wasserman, B. Z., Ye, L., Hamad, W. Y., & Burt, H. M. (2011). The use of nanocrystalline cellulose for the binding and controlled release of drugs. International Journal of Nanomedicine, 6, 321–330. https://doi.org/10.2147/ijn.s16749

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free